findmyKOL

Brendan Huang, MD, PhD

Basic profile

Pulmonary Disease

ORCIDNone on fileNPI
RegionSan Francisco, CA · WestSpecialtyPulmonary DiseaseFocusRespiratory
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationNot yet indexedOnline presenceNot yet checkedPayments2021 onwardNIH funding2022–2023Why? →

Brendan Huang is a Respiratory physician.

Overview

Scholarship

indexed output and impact (OpenAlex)

Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2022–2023

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

505 Parnassus Ave
Room M-987
San Francisco, CA 941432204

Telephone

415-476-1528

Provider last certified this registry record 3 Nov 2023.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    45.1%
    beta2-Adrenergic Agonist22.8%
    Albuterol Sulfate Hfa100%
    Part D31 patients
    Histamine-1 Receptor Antagonist8.9%
    Azelastine Hcl100%
    Part D<11 patients

    + 2 more classes in this area

  • Anti-infectives

    22.3%
    Macrolide Antimicrobial8.5%
    Azithromycin100%
    Part D<11 patients
    Penicillins with extended spectrum8%
    Amoxicillin-Clavulanate Potass100%
    Part D14 patients

    + 1 more class in this area

  • Nervous system

    22.3%
    Mood Stabilizer12.1%
    Carbamazepine Er100%
    Part D<11 patients
    Anti-epileptic Agent5.4%
    Zonisade100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B), 2023100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20222023 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”